High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Molina’s second quarter was complicated, with stability in Medicaid and outperformance in Medicare Advantage overshadowed by problems in the ACA exchanges. The trend was “unfortunate,” according to the insurer’s CEO.
Healthcare insurance company Molina Healthcare (NYSE:MOH) met Wall Street’s revenue expectations in Q2 CY2026, but sales fell by 4.8% year on year to $10.87 billion. On the other hand, the company’s full-year revenue guidance of $42 billion at the midpoint came in 5.1% below analysts’ estimates. Its non-GAAP profit of $1.51 per share was 7.8% above analysts’ consensus estimates.
Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.
Elevance Health is breaking the Medicare Advantage curse, and the insurer’s earnings could show it on Wednesday. Health insurer stocks have rallied this year after a tough run of rising medical costs that hampered earnings in 2024 and 2025. The results come just a day ahead of the monster of the industry, UnitedHealth Group Wall Street will be watching to see if these two companies can keep the momentum going.
SEM's Q1 EPS misses due to higher expenses and weaker patient days, even as revenues top estimates and rehab segment growth partly offsets pressure.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.